Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: Involvement of ERK1/2-Nrf2 signaling pathway

Life Sciences

Volumn 114, Issue 2, 2014, Pages 77-85

  Wang, Xiao Li ^a   Xing, Gui Hua ^a   Hong, Bo ^a   Li, Xiao Ming ^a   Zou, Yu ^a   Zhang, Xiao Jie ^a   Dong, Miao Xian ^a  

^a QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Chemical compounds studied in this article Curcumol (PubChem CID: 115067) 1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine (PubChem CID: 1388)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIPARKINSON AGENT; COPPER ZINC SUPEROXIDE DISMUTASE; GASTRODIN; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEME OXYGENASE 1; LAMIN B; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR NRF2; BENZYL ALCOHOL DERIVATIVE; GLUCOSIDE; NFE2L2 PROTEIN, MOUSE; PRIMER DNA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; LIPID PEROXIDATION; LOCOMOTION; MESENCEPHALON; MOTOR DYSFUNCTION; MOUSE; MPTP-INDUCED PARKINSONISM; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; ROTAROD TEST; SIGNAL TRANSDUCTION; TREATMENT DURATION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; ATAXIA; CHEMICAL STRUCTURE; CHEMISTRY; COMPLICATION; DRUG EFFECTS; GENETICS; METABOLISM; PARKINSONIAN DISORDERS; PHYSIOLOGY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANALYSIS OF VARIANCE; ANIMALS; ATAXIA; BENZYL ALCOHOLS; BLOTTING, WESTERN; DNA PRIMERS; GLUCOSIDES; GLUTATHIONE; HEME OXYGENASE-1; MALONDIALDEHYDE; MAP KINASE SIGNALING SYSTEM; MESENCEPHALON; MICE; MOLECULAR STRUCTURE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; REAL-TIME POLYMERASE CHAIN REACTION; ROTAROD PERFORMANCE TEST; SPECTROPHOTOMETRY, ULTRAVIOLET; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84908394198     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.08.004     Document Type: Article

References (54)

1. O.M. Abdel-Salam Drugs used to treat Parkinson's disease, present status and future directions CNS Neurol Disord Drug Targets 7 2008 321 342
2. A. Arocho, B. Chen, M. Ladanyi, and Q. Pan Validation of the 2-delta delta Ct calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts Diagn Mol Pathol 15 2006 56 61
3. A. Baillet, V. Chanteperdrix, C. Trocmé, P. Casez, C. Garrel, and G. Besson The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease Neurochem Res 35 2010 1530 1537
4. M.C. Barone, G.P. Sykiotis, and D. Bohmann Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease Dis Model Mech 4 2011 701 707
5. Z. Cai, J. Huang, H. Luo, X. Lei, Z. Yang, and Y. Mai Role of glucose transporters in the intestinal absorption of gastrodin, a highly water-soluble drug with good oral bioavailability J Drug Target 21 2013 574 580
6. A.N. Carvalho, C. Marques, E. Rodrigues, C.J. Henderson, C.R. Wolf, and P. Pereira Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice Mol Neurobiol 47 2013 662 672
7. S. Casani, R. Gómez-Pastor, E. Matallana, and N. Paricio Antioxidant compound supplementation prevents oxidative damage in a Drosophila model of Parkinson's disease Free Radic Biol Med 61 2013 151 160
8. L. Chen, Y. Ding, B. Cagniard, A.D. Van Laar, A. Mortimer, and W. Chi Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice J Neurosci 28 2008 425 433
9. P.C. Chen, M.R. Vargas, A.K. Pani, R.J. Smeyne, D.A. Johnson, and Y.W. Kan Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte Proc Natl Acad Sci U S A 106 2009 2933 2938
10. K.L. Cheung, J.H. Lee, L. Shu, J.H. Kim, D.B. Sacks, and A.N. Kong The Ras GTPase-activating-like protein IQGAP1 mediates Nrf2 protein activation via the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)-ERK pathway J Biol Chem 288 2013 22378 22386
11. C.T. Chu, D.J. Levinthal, S.M. Kulich, E.M. Chalovich, and D.B. DeFranco Oxidative neuronal injury. The dark side of ERK1/2 Eur J Biochem 271 2004 2060 2066
12. A. Cuadrado, P. Moreno-Murciano, and J. Pedraza-Chaverri The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease Expert Opin Ther Targets 13 2009 319 329
13. E. Dardiotis, G. Xiromerisiou, C. Hadjichristodoulou, A.M. Tsatsakis, M.F. Wilks, and G.M. Hadjigeorgiou The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides Toxicology 307 2013 17 23
14. B.N. Das, Y.W. Kim, and Y.S. Keum Mechanisms of Nrf2/Keap1-dependent phase II cytoprotective and detoxifying gene expression and potential cellular targets of chemopreventive isothiocyanates Oxid Med Cell Longev 2013 2013 839409 10.1155/2013/839409
15. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
16. H. Engler, R. Doenlen, C. Riether, A. Engler, M.B. Niemi, and H.O. Besedovsky Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease Brain Behav Immun 23 2009 518 526
17. B.A. Faucheux, M.E. Martin, C. Beaumont, J.J. Hauw, Y. Agid, and E.C. Hirsch Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease J Neurochem 86 2003 1142 1148
18. E. Grünblatt, S. Mandel, G. Maor, and M.B. Youdim Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss J Neurochem 77 2001 146 156
19. L. Gu, T. Cui, C. Fan, H. Zhao, C. Zhao, and L. Lu Involvement of ERK1/2 signaling pathway in DJ-1-induced neuroprotection against oxidative stress Biochem Biophys Res Commun 383 2009 469 474
20. J.A. Hutter-Saunders, H.E. Gendelman, and R.L. Mosley Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication J Neuroimmune Pharmacol 7 2012 279 288
21. Y. Izumi Dopaminergic neuroprotection via Nrf2-ARE pathway activation: identification of an activator from green perilla leaves Yakugaku Zasshi 133 2013 983 988
22. J.A. Johnson, D.A. Johnson, A.D. Kraft, M.J. Calkins, R.J. Jakel, and M.R. Vargas The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration Ann N Y Acad Sci 1147 2008 61 69
23. N.A. Kaidery, R. Banerjee, L. Yang, N.A. Smirnova, D.M. Hushpulian, and K.T. Liby Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease Antioxid Redox Signal 18 2013 139 157
24. S.L. Kowal, T.M. Dall, R. Chakrabarti, M.V. Storm, and A. Jain The current and projected economic burden of Parkinson's disease in the United States Mov Disord 28 2013 311 318
25. H. Kumar, I.S. Kim, S.V. More, B.W. Kim, Y.Y. Bahk, and D.K. Choi Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model Evid Based Complement Alternat Med 2013 2013 514095 10.1155/2013/514095
26. I. Lastres-Becker, A. Ulusoy, N.G. Innamorato, G. Sahin, A. Rábano, and D. Kirik α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease Hum Mol Genet 21 2012 3173 3192
27. L.C. Lin, Y.F. Chen, T.R. Tsai, and T.H. Tsai Analysis of brain distribution and biliary excretion of a nutrient supplement, gastrodin, in rat Anal Chim Acta 590 2007 173 179
28. N. Lindgren, R.K. Leak, K.M. Carlson, A.D. Smith, and M.J. Zigmond Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease J Neurosci Res 86 2008 2039 2049
29. L. Liu, B. Li, Y. Zhou, L. Wang, F. Tang, and D. Shao Antidepressant-like effect of Fuzi total alkaloid on ovariectomized mice J Pharmacol Sci 120 2012 280 287
30. Y.F. Lu, J. Liu, K.C. Wu, Q. Qu, F. Fan, and C.D. Klaassen Overexpression of Nrf2 protects against microcystin-induced hepatotoxicity in mice PLoS One 9 2014 e93013
31. D.W. Luchtman, Q. Meng, and C. Song Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease Behav Brain Res 226 2012 386 396
32. S.P. Markey, J.N. Johannessen, C.C. Chiueh, R.S. Burns, and M.A. Herkenham Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism Nature 311 1984 464 467
33. A. Maruyama, J. Mimura, N. Harada, and K. Itoh Nrf2 activation is associated with Z-DNA formation in the human HO-1 promoter Nucleic Acids Res 41 2013 5223 5234
34. F.C. Matheus, A.S. Aguiar Jr., A.A. Castro, J.G. Villarinho, J. Ferreira, and C.P. Figueiredo Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Behav Brain Res 235 2012 263 272
35. F. Morroni, A. Tarozzi, G. Sita, C. Bolondi, J.M. Zolezzi Moraga, and G. Cantelli-Forti Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease Neurotoxicology 36 2013 63 71
36. R.B. Mythri, G. Harish, and M.M. Bharath Therapeutic potential of natural products in Parkinson's disease Recent Pat Endocr Metab Immune Drug Discov 6 2012 181 200
37. H.K. Na, E.H. Kim, J.H. Jung, H.H. Lee, J.W. Hyun, and Y.J. Surh (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells Arch Biochem Biophys 476 2 2008 171 177
38. J. Peng, L. Peng, F.F. Stevenson, S.R. Doctrow, and J.K. Andersen Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration J Neurosci 27 2007 6914 6922
39. M. Pilleri, K. Koutsikos, and A. Antonini Is there room for new non-dopaminergic treatments in Parkinson's disease? J Neural Transm 120 2013 349 352
40. M. Reale, M. Pesce, M. Priyadarshini, M.A. Kamal, and A. Patruno Mitochondria as an easy target to oxidative stress events in Parkinson's disease CNS Neurol Disord Drug Targets 11 2012 430 438
41. A.I. Rojo, N.G. Innamorato, A.M. Martín-Moreno, M.L. De Ceballos, M. Yamamoto, and A. Cuadrado Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease Glia 58 2010 588 598
42. E. Santini, E. Valjent, A. Usiello, M. Carta, A. Borgkvist, and J.A. Girault Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in l-DOPA-induced dyskinesia J Neurosci 27 2007 6995 7005
43. R.J. Smeyne, and V. Jackson-Lewis The MPTP model of Parkinson's disease Brain Res Mol Brain Res 134 2005 57 66
44. X. Sun, L. Huang, M. Zhang, S. Sun, and Y. Wu Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta Toxicology 271 2010 5 12
45. S. Surendran, and S. Rajasankar Parkinson's disease: oxidative stress and therapeutic approaches Neurol Sci 31 2010 531 540
46. B. Thomas, and K.P. Mohanakumar Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum J Pineal Res 36 2004 25 32
47. F. Vaglini, C. Pardini, C. Viaggi, C. Bartoli, D. Dinucci, and G.U. Corsini Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease J Neurochem 91 2004 285 298
48. Q. Wang, G. Chen, and S. Zeng Distribution and metabolism of gastrodin in rat brain J Pharm Biomed Anal 46 2008 399 404
49. Y. Wang, Z. Wu, X. Liu, and Q. Fu Gastrodin ameliorates Parkinson's disease by downregulating connexin 43 Mol Med Rep 8 2013 585 590
50. T.P. Williamson, D.A. Johnson, and J.A. Johnson Activation of the Nrf2-ARE pathway by siRNA knockdown of Keap1 reduces oxidative stress and provides partial protection from MPTP-mediated neurotoxicity Neurotoxicology 33 2012 272 279
51. P. Yang, Y. Han, L. Gui, J. Sun, Y.L. Chen, and R. Song Gastrodin attenuation of the inflammatory response in H9c2 cardiomyocytes involves inhibition of NF-κB and MAPKs activation via the phosphatidylinositol 3-kinase signaling Biochem Pharmacol 85 2013 1124 1133
52. T. Zhang, F. Wang, H.X. Xu, L. Yi, Y. Qin, and H. Chang Activation of nuclear factor erythroid 2-related factor 2 and PPARγ plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury Br J Nutr 109 2013 223 235
53. X. Zhao, Y. Zou, H. Xu, L. Fan, H. Guo, and X. Li Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway Brain Res 1482 2012 13 21
54. C. Zhou, Y. Huang, and S. Przedborski Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance Ann N Y Acad Sci 1147 2008 93 104